Descriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence Tong LiClaudia Mello-ThomsPatrick C. Brennan Review 25 August 2016 Pages: 395 - 406
Cost–utility analyses of drug therapies in breast cancer: a systematic review Virginie NerichSopany SaingBernhard Holzner Review 30 August 2016 Pages: 407 - 424
Cost-effectiveness of febrile neutropenia prevention with primary versus secondary G-CSF prophylaxis for adjuvant chemotherapy in breast cancer: a systematic review T. YounisD. RaysonC. Skedgel Review 30 August 2016 Pages: 425 - 432
Association study confirms two susceptibility loci for breast cancer in Chinese Han women Minggui XuYihui XuBo Zhang Preclinical study 29 August 2016 Pages: 433 - 442
Phosphorylation of LSD1 at Ser112 is crucial for its function in induction of EMT and metastasis in breast cancer Jingxin FengGuiying XuYu Zhang Preclinical study 29 August 2016 Pages: 443 - 456
Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers Dena A. J. AhmadOla H. NegmEmad A. Rakha Preclinical study Open access 03 September 2016 Pages: 457 - 467
Exercise regulates breast cancer cell viability: systemic training adaptations versus acute exercise responses Christine DethlefsenChristian LillelundPernille Hojman Preclinical Study 06 September 2016 Pages: 469 - 479
Genomic profiling of breast cancer in African-American women using MammaPrint Raquel A. NunesLynette WraySandra M. Swain Clinical trial 27 August 2016 Pages: 481 - 488
Breast cancer-specific mortality in small-sized tumor with node-positive breast cancer: a nation-wide study in Korean breast cancer society Jai Min RyuHyouk Jin LeeKorean Breast Cancer Society Consortium Clinical trial 02 September 2016 Pages: 489 - 498
BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy A. S. HamyI. BiecheP. de Cremoux Clinical trial 03 September 2016 Pages: 499 - 511
Breast cancer risk prediction using a clinical risk model and polygenic risk score Yiwey ShiehDonglei HuElad Ziv Epidemiology 26 August 2016 Pages: 513 - 525
A collaborative approach to cancer risk assessment services using genetic counselor extenders in a multi-system community hospital Stephanie A. CohenDawn M. Nixon Epidemiology 31 August 2016 Pages: 527 - 534
Understanding racial differences in health-related quality of life in a population-based cohort of breast cancer survivors Laura C. PinheiroCleo A. SamuelBryce B. Reeve Epidemiology 01 September 2016 Pages: 535 - 543
A prospective study of endometriosis and risk of benign breast disease Leslie V. FarlandRulla M. TamimiStacey A. Missmer Epidemiology 07 September 2016 Pages: 545 - 552
Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women Lotte E. ElshofMichael SchaapveldJelle Wesseling Epidemiology Open access 08 September 2016 Pages: 553 - 563
Cost-effectiveness analysis of trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2): positive advanced breast cancer Quang A. LeYuna H. BaeJenny H. Kang Brief Report 29 August 2016 Pages: 565 - 573
Multiplexed imaging reveals heterogeneity of PI3K/MAPK network signaling in breast lesions of known PIK3CA genotype Thomas JacobJoe W. GrayTania Q. Vu Brief Report 31 August 2016 Pages: 575 - 583
Ready to clone: CNV detection and breakpoint fine-mapping in breast and ovarian cancer susceptibility genes by high-resolution array CGH Karl HackmannFranziska KuhleeAndreas Rump Brief Report 31 August 2016 Pages: 585 - 590
Erratum to: Exposure to polychlorinated biphenyl (PCB) congeners measured shortly after giving birth and subsequent risk of maternal breast cancer before age 50 Barbara A. CohnMary Beth TerryPiera M. Cirillo Erratum 31 August 2016 Pages: 591 - 592
